Back to Market Feed

Product Information

GRISEOFULVIN 125 MG/5 ML SUSP is a generic product labeled by Cipla USA Inc., priced at $0.2519 per ML under NDC 69097036108. Its NADAC has been published 467 times since May 17, 2017.

FDA first approved this application on Sep 10, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GRISEOFULVIN 125 MG/5 ML SUSP

grisofulvin
$0.2519per ML

Strength

125 mg/5mL

Manufacturer

Cipla USA Inc.

NDC

69097036108

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GRISEOFULVIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065354

FDA Approved

9/10/2007

TE Code

AB

On Market Since

3/6/2017

Pharmacological Classes

Decreased Mitosis
Microtubule Inhibition
Tubulin Inhibiting Agent

Price Statistics

The NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has been published 467 times since May 17, 2017, and over the history we have for it it has risen 30.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2519 per ML
All-time high$0.4099 (Dec 13, 2023)
All-time low$0.1508 (Jun 21, 2017)
52-week high$0.2989
52-week low$0.2471
Median price$0.2569
Average price$0.2785
Largest weekly change+28.2% (Jul 19, 2017)
Weeks tracked467
Tracking sinceMay 17, 2017

Price History

1W

+1.2%

1M

+1.2%

3M

-1.5%

6M

-4.7%

1Y

-15.7%

3Y

-38.5%

5Y

-11.1%

All

+30.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the grisofulvin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00472001304•Actavis Pharma, Inc.
$0.2519
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
62135096841•Chartwell RX LLC
$0.2519
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00713085004•Cosette Pharmaceuticals, Inc.
$0.3950
per ML
PACLITAXEL 300 MG/50 ML VIAL
Generic
61703034250•Hospira Inc.
$1.7700
per ML
PACLITAXEL 300 MG/50 ML VIAL
Generic
63323076350•Fresenius Kabi USA, LLC
$1.7700
per ML
PACLITAXEL 100 MG/16.7 ML VIAL
Generic
61703034222•Hospira Inc.
$1.8891
per ML
PACLITAXEL 100 MG/16.7 ML VIAL
Generic
63323076316•Fresenius Kabi USA, LLC
$1.8891
per ML
PACLITAXEL 30 MG/5 ML VIAL
Generic
61703034209•Hospira Inc.
$2.1290
per ML
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00115172401•Amneal Pharmaceuticals of New York LLC
$2.7523
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00781582701•Sandoz Inc.
$2.7523
per EA

Frequently asked questions

What is the NADAC price of GRISEOFULVIN 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN 125 MG/5 ML SUSP, manufactured by Cipla USA Inc., is $0.2519 per ML (NDC 69097036108), effective Aug 19, 2026.

How has the price of GRISEOFULVIN 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has risen 30.7%. It has been tracked across 467 weekly CMS publications since May 17, 2017.

What are the highest and lowest recorded NADAC prices for GRISEOFULVIN 125 MG/5 ML SUSP?

Since May 17, 2017, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has ranged from a low of $0.1508 (Jun 21, 2017) to a high of $0.4099 (Dec 13, 2023), with a median of $0.2569 per ML.

Are there cheaper alternatives to GRISEOFULVIN 125 MG/5 ML SUSP?

No other NADAC-published product currently shares the active ingredient and strength of GRISEOFULVIN 125 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GRISEOFULVIN 125 MG/5 ML SUSP?

GRISEOFULVIN 125 MG/5 ML SUSP (NDC 69097036108) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.